Regional disparities in osteosarcoma and soft tissue sarcoma treatment across Northwest China: a cross-sectional multicenter survey
- 1Department of Bone and Soft Tissue Tumors and Melanoma, Affiliated Tumor Hospital of Xinjiang Medical University
Abstract
Osteosarcoma and soft tissue sarcoma are rare but aggressive malignancies requiring multidisciplinary care. Despite consensus guidelines, real-world treatment patterns across Northwest China remain poorly characterized. We conducted a cross-sectional, questionnaire-based multicenter survey of 67 hospitals treating osteosarcoma and 60 treating soft tissue sarcoma across three regional clusters in Northwest China (Xinjiang-Qinghai, Gansu-Ningxia, Shaanxi-Shanxi). The survey instrument, developed through literature review and expert panel review with pilot testing, covered seven domains: hospital demographics, multidisciplinary team implementation, chemotherapy protocols, tumor necrosis rate assessment and surgical management. Regional comparisons were performed using Fisher’s exact test and Chi-square tests. Patient volume distribution differed significantly between disease types, with osteosarcoma centers concentrated in lower-volume strata compared with soft tissue sarcoma centers (Chi-square = 15.92, p = 0.003). Tumor necrosis rate detection showed a decreasing trend from 80.0% in Xinjiang-Qinghai to 50.0% in Shaanxi-Shanxi; however, this difference did not reach statistical significance (p = 0.057). Neoadjuvant methotrexate dosing exhibited significant regional variation (Chi-square = 13.28, p = 0.039), and anti-angiogenic TKI utilization demonstrated highly significant regional disparity (Chi-square = 22.52, p < 0.001). Amputation rates declined west-to-east from 27.5% to 10.6%, while limb-salvage rates were comparable. Substantial regional disparities exist in sarcoma treatment across Northwest China, highlighting the need for standardized treatment protocols, regional resource equalization, and policy interventions to ensure equitable access to guideline-concordant sarcoma care.
Related
- Chronic Kidney Disease–Associated Pruritus in Danish Dialysis Patients: A Cross-Sectional Multicenter Study of Prevalence, Disease Burden, and Current Treatment Practices
- Disparities in treatment burden in Peru among people with multiple long-term conditions by geography and healthcare facility: A cross-sectional study
- Body Mass Index, Cardiometabolic Treatment Patterns and Multifactorial Risk‐Factor Control in Chinese Adults With Type 2 Diabetes: A Multicenter Cross‐Sectional Study
- Association Between Depressive Symptom Severity and Treatment Adherence Among Primary Care Patients with Hypertension in Taizhou, East China: A Multicenter Cross-Sectional Study
- Ethnoracial disparities in emergency department triage are more pronounced in lower-risk visits: a multicenter study
BibTeX
@article{yang2026regional,
title = {{Regional disparities in osteosarcoma and soft tissue sarcoma treatment across Northwest China: a cross-sectional multicenter survey}},
author = {Wenpeng Yang and Junshen Wu and Maierdanjiang Maihemuti and Suzhi Ji and Renbing Jiang},
journal = {Scientific Reports},
year = {2026},
month = aug,
doi = {10.1038/s41598-026-68947-z},
url = {https://doi.org/10.1038/s41598-026-68947-z},
note = {CC BY},
}
RIS
TY - JOUR
TI - Regional disparities in osteosarcoma and soft tissue sarcoma treatment across Northwest China: a cross-sectional multicenter survey
AU - Wenpeng Yang
AU - Junshen Wu
AU - Maierdanjiang Maihemuti
AU - Suzhi Ji
AU - Renbing Jiang
PY - 2026
DA - 2026/08/01
JO - Scientific Reports
DO - 10.1038/s41598-026-68947-z
UR - https://doi.org/10.1038/s41598-026-68947-z
AB - Osteosarcoma and soft tissue sarcoma are rare but aggressive malignancies requiring multidisciplinary care. Despite consensus guidelines, real-world treatment patterns across Northwest China remain poorly characterized. We conducted a cross-sectional, questionnaire-based multicenter survey of 67 hospitals treating osteosarcoma and 60 treating soft tissue sarcoma across three regional clusters in Northwest China (Xinjiang-Qinghai, Gansu-Ningxia, Shaanxi-Shanxi). The survey instrument, developed through literature review and expert panel review with pilot testing, covered seven domains: hospital demographics, multidisciplinary team implementation, chemotherapy protocols, tumor necrosis rate assessment and surgical management. Regional comparisons were performed using Fisher’s exact test and Chi-square tests. Patient volume distribution differed significantly between disease types, with osteosarcoma centers concentrated in lower-volume strata compared with soft tissue sarcoma centers (Chi-square = 15.92, p = 0.003). Tumor necrosis rate detection showed a decreasing trend from 80.0% in Xinjiang-Qinghai to 50.0% in Shaanxi-Shanxi; however, this difference did not reach statistical significance (p = 0.057). Neoadjuvant methotrexate dosing exhibited significant regional variation (Chi-square = 13.28, p = 0.039), and anti-angiogenic TKI utilization demonstrated highly significant regional disparity (Chi-square = 22.52, p < 0.001). Amputation rates declined west-to-east from 27.5% to 10.6%, while limb-salvage rates were comparable. Substantial regional disparities exist in sarcoma treatment across Northwest China, highlighting the need for standardized treatment protocols, regional resource equalization, and policy interventions to ensure equitable access to guideline-concordant sarcoma care.
SN - 2045-2322
ER -